Bayer 20324 ON-TRK
ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib
A Phase 1, Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Combination of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) and/ or Chemotherapy in Subjects with Locally Advanced or Metastatic Solid Tumors
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
A Study to Evaluate Circulating Tumor DNA ConCORdance for Determination of Mutation Status in Liquid Biopsy in Subjects with known mutations(ACCORD)
©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.